Cargando…

Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial

Detalles Bibliográficos
Autores principales: Farahmand, S, Ahmadi, O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934121/
http://dx.doi.org/10.1186/cc8714
_version_ 1782186236706816000
author Farahmand, S
Ahmadi, O
author_facet Farahmand, S
Ahmadi, O
author_sort Farahmand, S
collection PubMed
description
format Text
id pubmed-2934121
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29341212010-09-08 Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial Farahmand, S Ahmadi, O Crit Care Poster Presentation BioMed Central 2010 2010-03-01 /pmc/articles/PMC2934121/ http://dx.doi.org/10.1186/cc8714 Text en Copyright ©2010 BioMed Central Ltd.
spellingShingle Poster Presentation
Farahmand, S
Ahmadi, O
Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title_full Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title_fullStr Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title_full_unstemmed Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title_short Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
title_sort adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934121/
http://dx.doi.org/10.1186/cc8714
work_keys_str_mv AT farahmands addingultralowdoseoralnaltrexonetomorphineadoubleblindrandomizedclinicaltrial
AT ahmadio addingultralowdoseoralnaltrexonetomorphineadoubleblindrandomizedclinicaltrial